Zevra Therapeutics
ZVRA
ZVRA
48 hedge funds and large institutions have $139M invested in Zevra Therapeutics in 2015 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% more capital invested
Capital invested by funds: $104M → $139M (+$34.7M)
Holders
48
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$16.7M | |
| 2 | +$2.99M | |
| 3 | +$2.88M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.68M |
| 5 |
Goldman Sachs
New York
|
+$1.06M |
Top Sellers
| 1 | -$1.14M | |
| 2 | -$1.14M | |
| 3 | -$629K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$404K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$347K |